However, the presence of transforming growth factor-beta (TGF-β), particularly TGF-β1 secreted by tumor and stromal cells within the TME, is responsible for immune exclusion and resistance to anti-PD-L1 antibodies in metastatic cancers. The gene discussed is TGFB1; the disease is metastatic malignant neoplasm.